ArticleIn vivo (Athens, Greece)

Combined Therapy of ATRA and Imatinib Mesylate Decreases BCR-ABL and ABCB1/MDR1 Expression Through Cellular Differentiation in a Chronic Myeloid Leukemia Model.

Camila Albuquerque Pinto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.